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The presence of peroxisomal membrane gliosis was examined in liver 
biopsies from eleven patients presenting the clinical and biochemical 
picture of a generalized peroxisomal disorder (Zellweger syndrome, 
neonatal adrenoleukodystrophy, infantile Refsum disease and variants 
of these syndromes). A polyclonal antibody raised against the mem* 
brane of human liver peroxisomes and recognizing a 43 kDa peroxi­
somal membrane protein (PMP) was used. In human control liver the 
antibodies react in a distinct and specific way with the peroxisomal 
membrane.
Two types of organelles with an immunoreactive membrane were 
identified in the liver parenchymal cells of the patients: organelles con­
taining an electron-dense core and organelles with electron transpar­
ent contents. Both types may co-occur in the same patient; in two 
patients they were found in the same cell. The organelles are rare, and 
their number varies between patients. The first type possibly corre- 
spoil (Is to the previous morphological description of aberrant peroxi­
somes in the liver of patients with Zellweger syndrome, neonatal adre- 
noleukodystrophy and infantile Refsum disease. The empty looking 
organelles have not been reported previously in the liver, some of the 
“empty” organelles seem to be enclosed by a double membrane.
Morphometrical analysis in three patients indicated that both types 
of organelles (corrected mean d-circle 0.271-0.306 jam for the “empty” 
and the dense core organelles, respectively) are smaller than the per­
oxisomes in postnatal control liver and in fetal liver.
In one patient (infantile Refsum disease) immunoreactive organ­
elles were not detected. The organelles with the electron-dense core 
were not found in two patients. In one of them, described clinically 
and biochemically as a mild Zellweger variant, very few cells showed 
numerous small organelles enclosing a morphologically normal matrix
l> Dr, Marc Espeel, Department of Anatomy, Embryology and Histo­
logy, University of Gent, Godshuizenlaan 4, B-9000 Gent/Belgium.
which contained at least the peroxisomal matrix proteins catalase, 
acyl-CoA oxidase, 3-ketoacyl-CoA thiolase, and alamne/glyoxylate 
aminotransferase; their membrane showed 43 kDa PMP immunoreac- 
tivity.
The dense core organelles and the empty-lookinig organelles were 
not found in human control livers, in which solely the membrane of 
normal peroxisomes was labeled. It is therefore suggested that both 
types of organelles, identified by their immunoreactivity for the
43 kDa PMP, represent aberrant peroxisomes. The finding of mor­
phologically empty vesicles is in accordance with the concept that the 
defect in these disorders is at the level of the assembly of import com­
petent peroxisomes. On the other hand, the findings also indicate that 
at least in one patient the defect is not present in all parenchymal cells: 
peroxisomes containing at least four matrix proteins were present in a 
minority of the cells.
Introduction
Peroxisomes are single membrane-limited cell organelles, 
which are involved in various anabolic and catabolic processes 
(for review, see [35]). The importance of their role in human 
metabolism has become clear after the recognition of a dis­
tinct group of inherited diseases, the peroxisomal disorders 
[15]. These disorders are subdivided in three groups, reflecting 
the deficiency of all (group I), multiple (group II) or a single 
(group III) peroxisomal enzyme function [39]. In the Cerebro- 
Hepato-Renal syndrome (CHRS; Zellweger syndrome; per­
oxisomal disorder group I), which is the prototype of the per­
oxisomal disorders and represents the most severe clinical con­
dition, morphologically recognizable peroxisomes are absent 
in the liver and kidney [8].
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In cultured skin fibroblasts from CHRS patients, the peroxi­
somal matrix and membrane proteins are normally synthe­
sized [26, 32]. Some of the enzymes remain localized in the 
cytoplasm where they may preserve their enzyme activity, e.g. 
catalase and alanine/glyoxylate aminotransferase [37, 38]; 
others are readily degraded [33],
In these cells large and rare vesicles were found with a mem­
brane that was immunoreactive for an antiserum raised 
against peroxisomal membrane proteins. These organelles, 
which looked largely empty and were designated as “mem* 
brane ghosts”, were considered to represent peroxisomes 
which are unable to import their matrix components, and an 
import defect was suggested to be at the base of these disor­
ders [22, 23]. So far, two different peroxisomal targeting sig­
nals which are necessary to direct matrix proteins to the 
peroxisome in mammalian cells, were identified: a carboxy- 
terminal S KL-trip ep tide (PTSI) and an ami no-terminal leader 
sequence (PTSII); the involved translocation mechanisms 
remain as yet unknown (for review, see [30]).
Since the work by Santos et aL [22, 23], membrane ghosts 
have also been identified in cultured skin fibroblasts from pa­
tients with infantile Refsum disease, neonatal adrenoleuko- 
dystrophy and hyperpipecolic acidemia [4]. Experimental evi­
dence for an import defect in these cells was provided by mi­
croinjection experiments of synthetic proteins carrying the 
car boxy-terminal SKL signal [36].
Complementation analysis with fibroblasts revealed that the 
generalized peroxisomal disorders segregate in at least nine 
complementation groups; there is no obvious correlation 
between the genotype and the phenotype [27]. It has recently 
been shown that in cultured fibroblasts from complementation 
group IV the import via the amino-terminal presequence of 
3-ketoacyl-CoA thiolase is unaffected [17].
Immunoblotting studies in the liver of patients with a gen­
eralized peroxisomal disorder have demonstrated that the per­
oxisomal membrane proteins (PMPs) were normally present 
[14, 28] or that they were present in variable, diminished 
amounts and associated with a membrane fraction [7, 40]. 
Other studies reported the absence of peroxisomal membrane 
proteins in several patients [1, 31]. These studies do not
exclude the possibility that the PMPs, even when they are 
found in association with a membranous structure, have 
inserted into a wrong subcellular compartment [28]. To 
address this question, we have examined by immunocyto- 
chemistry the subcellular localization of a 43kDa PMP -  
which was recently isolated from human liver peroxisomes [24] 
-  in the liver parenchymal cells of eleven patients with a 
generalized peroxisomal disorder.
Materials and methods
Antibodies
Polyclonal antisera were raised in rabbits against the membrane of 
human liver peroxisomes isolated from fresh and frozen human liver 
according to Alvarez et al, [2]. On immunoblots one serum cross­
reacted with PMPs with a molecular mass of 112, 69 and 43 kDa. From 
this serum monospecific antibodies against the 43 kDa PMP were 
obtained by affinity purification. The affinity-purified antibodies 
reacted mainly with the 43 kDa PMP and to a much lesser extent with 
the 69 kDa PMP [24].
The following polyclonal antibodies, raised in rabbits, against 
peroxisomal matrix proteins were used: catalase (IgG fraction from 
serum raised against bovine liver catalase; Rockland Laboratories, 
Gilbertsville, PA/USA, Code N o.200-4151); acyl-CoA oxidase (IgG 
fraction raised against the rat liver enzyme; supplied by Dr. A. Volkl, 
Heidelberg/Germany), 3-ketoacyl-CoA thiolase (IgG fraction raised 
against the rat liver enzyme; supplied by Dr. T. Hashimoto, Nagano/ 
Japan) and alanine/glyoxylate aminotransferase (full serum raised 
against the human liver enzyme; supplied by Dr. R. J. A. Wanders and 
Dr. R. B, H. Schutgens, Amsterdam/The Netherlands).
Immunocytochemical procedures
In a first experiment, preembedding immunolabeling in human control 
liver was tested because this method (/) maximally preserves antigeni­
city by avoiding embedding, and (ii) it allows a sensitive control to 
check for a possible cross-reaction with the membrane of other cell 
organelles like the endoplasmic reticulum and the mitochondria.
For this purpose two biopsies from human control liver were fixed 
with 4% commercial formaldehyde in 0.1m sodium cacodylate buffer 
(pH7.4) during 24h at room temperature, Cryostat sections (24|im) 
were immunolabeled following the procedure described in [4]. Protein 
A colloidal gold (10 nm), prepared according to Slot and Geuze [29],
Tab. I. Examined patients and types of 43 kDa PMP immunoreactive organelles.
Patient Diagnosis Type of 43 kDa PMP immunoreactive organelles Group*
Initials Sex Age at b iopsy Clinical and biochemical
DE M 9 years neonatal adrenoleukodystrophy; Dense core organelles and empty vesicles A
patient 2 described in [34]
OG M 11 days classical Zellweger syndrome, died at the Dense core organelles and empty vesicles A
age o f 5 months
M M b M 1st: 6 m onths m ild  Zellweger variant Empty vesicles
2nd: 27 m onths Empty vesicles and small, numerous peroxisomes B
in a very few  cells
NEGC F 10 years m ild  Zellweger variant Dense core organelles and empty vesicles A
MD M 1.5 m onths generalized peroxisomal disorder Dense core organelles and empty vesicles A
ACG F 11 m onths Infantile Refsum disease Dense core organelles and empty vesicles A
CCC M 2 yea rs Infantile Refsum disease Dense core organelles and empty vesicles A
DL M 6 months generalized peroxisomal disorder Dense core organelles and empty vesicles A
IB F 7.5 months generalized peroxisomal disorder Empty vesicles C?
MNC M 20 years Infantile Refsum disease Dense core organelles and empty vesicles A
CNC F 15.5 years Infantile Refsum disease Immunoreactive organelles not detected
8 See Discussion. - b Patient M M  showed normal levels o f phytanic acid. Phytanic acid accumulation in patients w ith a generalized peroxisomal 
d isorder is age and diet dependent [39], -  Patients AC and CC and patients MN and CN are siblings. The latter were clin ically and biochemically 
described [21].
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was used for immunodetection. Subsequently the sections were post- 
fixed with 1 % osmium tetroxide and embedded in LX-112 resin (Ladd 
Research Industries, Burlington, VT/USA). Ultrathin sections, col­
lected on 300 mesh cupper grids, were conventionally poststained with 
uranyl acetate and lead citrate and examined in a JEOL 100B electron 
microscope.
A postembedding on-grid immunolabeling procedure was applied to 
ultrathin sections of control and patient livers. Samples, fixed as men­
tioned above, were postfixed with 0.5 % glutardialdehyde during 1 h at 
4°C and further processed for embedding in Lowicryl K4M (Balzers 
Union/Liechtenstein) or in Unicryl (BioCell International, Cardiff/ 
UK)» a recently introduced acrylate resin [25]. The labeling procedure, 
making use of 15-nm colloidal conjugated to protein A, has been 
described elsewhere [5]. Negative controls were incubated with normal 
rabbit serum or the IgG fraction of this serum (Dakopatts, Copen­
hagen/Denmark).
rapy; recently, impaired liver transferase functions were found). The 
control specimens for postembedding were, besides the above m en­
tioned samples, two biopsies from adult males with alcoholic steatosis.
The examined patients are listed in Table I. They all showed the clin­
ical picture of a generalized peroxisomal disorder which was confirmed 
in all cases by biochemical analysis (i.e. reduced piasmalogen levels, 
increased levels of very long chain fatty acids, phytanic and pipecolic 
acid, and an accumulation of bile acid intermediates).
Diaminobenzidine cytochemistry
Sections from all the patients’ samples were incubated for the cyto- 
chemical demonstration of catalase activity according to Roels et al.
[18]. Catalase containing peroxisomes could not be detected at the 
light and electron microscopy level in none of the samples (not 
shown).
Liver specimens
The control specimens for preembedding immunolabeling were two 
biopsies from adult females, suffering from chronic hepatitis B and an 
unknown etiology (history of cervix carcinoma, followed by radiothe-
Morphometry
In four patients morphometric analysis was done on calibrated elec­
tron micrographs of immunolabeled ultrathin Unicryl sections, accord­
ing to previously described procedures [3].
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Fig. 1, Preembedding immunolabeling for the 43 kDa peroxisomal , 
membrane protein in a control liver, revealing the high specificity of 
the antibodies for the peroxisomal membrane. The gold particles 
(10 nm) only decorate the membrane of the peroxisomes (arrows). 
Labeling at the membrane of the mitochondria (M) or of the endo­
plasmic reticulum is absent. Glycogen rosettes (arrowheads) and a 
lipid droplet (L) are seen. -  Bar 0.5 ^m. -  37 400 X.
Fig. 2. Postembedding labeling (15-nm gold particles) for the 43 kDa 
peroxisomal membrane protein in a control liver (ultrathin Unicryl 
section). The membrane of the peroxisomes (arrows) is labeled; the 
labeling density is lower in comparison with the preembedding label­
ing. The organelle indicated by the asterisk possibly represents an unla­
beled peroxisome. -  Bar 0.5 \im. -  50 000 X.
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Figs. 3 to 8» Different types of organelles with an immunoreactive 
membrane for the 43 kDa peroxisomal membrane protein. -  Figs. 3, 4. 
Organelles with an electron-dense core surrounded by a halo; their 
membrane is immunoreactive. The size and morphology of the organ­
elles is remarkably similar. -  Fig. 3. Patient DL -  Fig. 4. Patient MD< -  
F ig .5, Patient MD. An “empty” organelle, with a (double) immuno­
reactive membrane. -  Fig. 6. Patient OG, TWo “empty” vesicles with
an immunoreactive membrane. These organelles were numerous, -  
Fig. 7. Patient IB. A vesicle with an immunoreactive membrane, which 
seems to enclose a very dispersed matrix. The size of this organelle is 
similar to that of a normal peroxisome. -  Fig. 8. Patient CC. “Empty" 
vesicle with an immunoreactive membrane. -  Bars 0.2 \im (Figs. 3-6, 
8), 0.5 jim (Fig, 7). -7 9  000 x (Figs.3-5), 63 200x (Figs.6, 8), 56800x 
(Fig. 7).
Results
Control liver
In the preembedding immunolabeling experiments using the 
affinity-parified antibodies against the 43 kDa PMP, a highly 
specific immunoreactivity of the peroxisomal membrane was 
found in both samples. The membrane of other cell organelles 
remained unlabeled (Fig. 1). In the postembedding labeling 
the peroxisomal membrane was labeled at a lower density as 
compared with preembedding labeling; it is possible that some 
organelles remained unlabeled (Fig. 2). Control incubations 
with normal rabbit serum were negative in all samples and 
experiments (not shown).
Patients
Imm imo cytochemistry. Two types of immunoreactive mem­
branous structures were identified. The first type is an organ­
elle containing an electron-dense core that is separated from
Figs. 9 to 14. Patient MM. -  Fig. 9. “Empty” vesicle with a (double?)
43 kDa PMP immunoreactive membrane. -  Fig. 10. Numerous, small 
organelles with a (single) 43 kDa PMP immunoreactive membrane and 
enclosing a normal appearing matrix, were present in a few cells. -  
Figs. 11 to 14. The organelles shown in (Fig. 10) contain catalase 
(Fig. 11), acyl-Co A oxidase (Fig. 12), 3-ketoacyI-CoA thiolase (Fig. 13) 
and alanine/glyoxylate aminotransferase (Fig. 14). The labeling pattern 
for catalase (Fig. 11) reveals numerous gold particles over the cyto­
plasm. The mitochondrial profiles (M) and the cisternae of the endo­
plasmic reticulum (arrowheads) are devoid of gold particles. -  Bars 
0.2 [un (Figs. 9, 10), 0.20 i^m (Figs. 11-14). -  47 400 X (Figs. 9, 10), 
37900X (Figs. 11-14).
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the membrane by an electron-lucent halo. It was found in pa­
tients DE, NEGC, OG, MD, AC, CC, DL, and MN. The 
shape and appearance of these organelles is remarkably simi­
lar in all patients (Figs. 3,4).
The second type are organelles which most often look 
empty, i.e. their contents are electron translncent (Figs. 5-9). 
They were found In all the patients, except for CN. Occasion­
ally some vesicles seem to contain a very dispersed matrix 
(Fig. 7). In contrast to the organelles with the electron-dense 
core, which are delineated by a single membrane, some organ- 
*
elles of the second type seem to be enclosed by a double mem­
brane (Figs. 5, 9).
Both types of organelles may co-occur in the same patient 
(see Tab. I and Figs. 4 and 5); in patients NEGC, DL and OG 
they were found in the same cell. In patients MM and IB only 
organelles of the second type were found. The results are sum­
marized in Table I.
As evaluated from the ultrathin sections, the number of 
labeled organelles varies between the patients. In most sam­
ples the organelles are very rai*e, and many cells are seen with­
out immunoreactive organelles.
None of these organelles were found in the control livers. 
Control incubations with normal rabbit serum were negative 
in all samples (not shown).
Besides the empty vesicles in patient MM (Fig. 9), the anti­
body reacted in a very few cells with the membrane of numer­
ous small organelles enclosing a homogeneous matrix and 
appearing as small peroxisomes (Fig. 10). The peroxisome 
nature of these organelles was further confirmed by immuno- 
cytochemistry: catalase, alanine/glyoxylate aminotransferase, 
acyl-CoA oxidase and 3-ketoacyl-CoA thiolase were localized 
in these organelles (Figs. 11-15). Besides the peroxisomal 
localization of catalase in these cells, there was also evidence 
for a cytoplasmic localization of catalase: numerous gold par­
ticles were present in the cytoplasm while the mitochontrial 
profiles and the cisternae of the endoplasmic reticulum were 
devoid of label (Fig. 11).
Morphometry. The mean diameter (d-circle) of the 43kDa 
PMP immunoreactive organelles was measured in patients 
OG, MD and DL and of the “empty” organelles and the per­
oxisomes in patient MM; the data are summarized in Table II. 
The d-circle of the 43kDa PMP immunoreactive organelles 
varies between 0.196 (ini (dense core organelle in patient DL) 
and 0.311 [xm (“empty” organelle in patient MM). Student’s f- 
test indicated that in patients MD and OG the mean d-circle 
of the organelles with the electron-dense core is significautly 
smaller (P <  0.015) than that of the empty-looking organelles. 
ANOVA analysis showed that the d-circle of both types of 
organelles does not significantly differ between the three pa­
tients. Both types are smaller than the peroxisomes in human 
embryonic and postnatal liver.
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Fig. 15. Light microscopy of the heterogeneity of peroxisome occur­
rence in the liver parenchyma of patient MM. Four parenchymal cells 
with peroxisomes (arrowheads) are seen among parenchymal cells 
without peroxisomes. The organelles are revealed as dark granules 
after immunostaining against alanine/glyoxylate aminotransferase in 
combination with silver enhancement on a semithin Unicryl section; 
nuclei counterstained with Toluidin Blue. ~ Bar 20^ni. -  560 X.
Tab. II. Size parameters of the 43 kDa immunoreactive organelles in 
four patients and of peroxisomes in control liver.
d-circle (in ¡mm) 
Mean (± S.E.M.)a
Corrected
mean
Maximum
Patients
OG
"E m pty" organelles 
(n=24)b
Organelles w ith  core
(n=10)b
0.257 (±0.013) 
0.201 (±0.011)
0.306
0.235
0.36
0.25
DL
"E m pty" organelles 
{n=22)b
Organelles w ith  core 
(n«16)b
0.231 (±0.010) 
0.212 (±0.008)
0.271
0.246
0.30
0.30
MD
"E m pty" organelles 
(n=46)b
Organelles w ith  core 
(n«22)b
0.237 (±0.009) 
0.196 (±0.010)
0.280
0.231
0,41
0.28
MM
"E m pty" organeiles 
(n=14)b
Peroxisomes (n=108)
0.311 (±0.016) 
0.324 (±0.007)
0.367
0.387
0.45
0.51
Controls
Postnatal 
adult (n-951)c 
infantd 
6 weeks (n-117)
4 m onths (n-135)
0.525 (±0.017)
0.445 (±0.013) 
0.518 (±0.012)
0.643
0.555
0.640
0.940
0.848
1.027
Embryonic41
6 weeks (n=39)
7 weeks (n=87)
0.334 (±0.008) 
0.348 (±0.007)
0.401
0.415
0.455
0,474
a Standard error o f the mean. -  b Frequency o f labeled organelles 
explains the low  numbers measured. -  c Seven samples (age 46±7 
years), from  De Craemer et al. [3]. ~ d Postmenstrual age, from Espeel 
et al. [6].
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In patient MM, the empty organelles and the genuine per­
oxisomes have a similar mean d-circle which is smaller than in 
postnatal control liver, but of a similar magnitude as in 
embryonic liver. The empty organelles in MM are significantly 
larger (P < 0.015) than in the three other patients.
Discussion
With polyclonal antibodies against a 43kDa peroxisomal 
membrane protein isolated from human liver peroxisomes, 
two types of organelles with an immunoreactive membrane in 
the liver of patients with a generalized peroxisomal disorder 
were identified. By immunolabeling in human control livers, it 
was shown that the antibodies react in a distinct and highly 
specific way with the peroxisomal membrane only.
The first type of immunoreactive organelles, i.e. the organ­
elles with the electron-dense core, corresponds to the de­
scription “sparse, scattered and small organelles, with a dense 
matrix that was separated from the membrane” in the liver of 
patients with Zellweger syndrome, neonatal adrenoleuko- 
dystrophy and infantile Refsum disease [9,11,13,16, 34]. In a 
recent immunocytochemical study [13] such organelles were 
found in two of four Zellweger patients, in one NALD and 
two IRD patients; the diameter (uncorrected d-circle) varies 
between 0,20 and 0.26 |im. Only in the IRD patients the mem­
brane of the organelles was immunoreactive for an antibody 
against the 68 kDa PMP from mouse liver peroxisomes [13]. In 
agreement with these observations, we did not find the dense 
core organelles in all the patients.
The second type of organelles has not been described in the 
liver previously. As most of these organelles do not contain a 
morphologically recognizable matrix, their appearance is in 
agreement with the original description of “empty” membrane 
ghosts in cultured skin fibroblasts from a CHRS patient [23]. 
Remarkably, some of these organelles seem to be enclosed by 
a double membrane. The resolution of the colloidal gold label­
ing combined with the relatively poor contrast of membranes 
in acrylate resin sections does not allow to determine unequiv­
ocally whether both membranes are labeled. The following 
points with respect to the presence of a double membrane 
should be mentioned: 1) at least some of the peroxisomal 
ghosts in cultured fibroblasts are enclosed by a double or 
multiple membrane (personal communication by Dr. A. 
Motley, Amsterdam; cited with permission); 2) the image of a 
vesicle with a double membrane might be the result of a sec­
tion through a collapsed, single membrane-limited organelle; 
3) referring to the observations in CHRS fibroblasts that 
lysosomal hydrolases are associated with the peroxisomal 
membrane ghosts [10], the double membrane aspect might 
correspond with an early phase in the process of autophagic 
degradation.
In an attempt to classify the types and occurrence of immu­
noreactive organelles in the examined samples, three groups 
can be considered: group A (patients DE, NEGC, OG, MD, 
AC, CC, DL and MN), in which dense core organelles and 
empty vesicles co-occur, group B (patient MM) with the pres­
ence of empty vesicles in the major part of the parenchymal 
cells and numerous small peroxisomes in few cells, and group 
C (patient IB) with the empty vesicles only. It might be inter­
esting to compare the classification with the complementation 
groups to which the patients belong; this awaits further experi­
ments.
Peroxisomal membrane ghosts in human liver 325
With a polyclonal antibody against the 68 kDa mouse liver 
PMP, Hughes et al. [13] found no immunoreactive empty- 
looking organelles in the liver of their patients with a general­
ized peroxisomal disorder. In a previous study with a polyclon­
al antibody against a 70kDa peroxisomal membrane protein 
from rat liver peroxisomes, we could not demonstrate immu­
noreactive organelles in the liver from six patients with a gen­
eralized peroxisomal disorder, including the present cases 
MM, OG and DE [21]. Similar negative results from immuno- 
cytochemistry with the same antibody probe were obtained in 
three Zellweger patients by another group (Dr. S, Yokota, per­
sonal communication; cited with written permission). It 
should also be remembered that in liver immunoblots from 
several patients, in which the same antibodies were used, 
absence of the 70 kDa peroxisomal membrane protein was 
reported [1, 31]. In addition to patient CN, in two patients 
with multiple defects of peroxisomal metabolism and showing 
a mosaic distribution of peroxisome occurrence in the liver 
parenchyma, we could not detect 43 kDa immunoreactive 
organelles in the cells without peroxisomes (Espeel et al., in 
press, Hepatology).
The results from morphometry in three patients show that 
both types of organelles are smaller than the peroxisomes in 
infant and adult control liver. In early embryonic human liver, 
peroxisomes also are of reduced size. At this stage, catalase 
activity shows a pronounced heterogeneity between organ­
elles, many being negative and the peroxisomal (3-oxidation 
enzymes cannot yet be detected [6]. This suggests that the 
aberrant organelles in the patients did not undergo a normal 
growth during ontogeny. The data differ from the membrane 
ghosts in fibroblasts, which were described as enlarged. In per­
oxisomal disorder patients from group II and III (see Intro­
duction), the hepatic peroxisomes are, except for primary 
hyperoxaluria type I and X-linked adrenoleukodys trophy, 
enlarged (for review, see [19]); extreme enlargement was 
reported in rhizomelic chondrodysplasia punctata and variants 
of this syndrome [5, 12 , 20].
No immunolabeling was detected in the dense core organ­
elles and over the profiles corresponding to empty-looking 
organelles after incubation for catalase and alanine/glyoxylate 
aminotransferase in three patients studied in this respect (OG, 
DL, MD). Also after incubation for catalase activity with di- 
aminobenzidine no reaction product was found in the dense 
core organelles. This is in agreement with Hughes et al. [13], 
who found no labeling for catalase in the dense core organ­
elles of the CHRS and NALD patients; in the IRD patients 
these authors observed a reduced labeling density for catalase.
The presence of import competent peroxisomes in a few 
cells in the liver of patient MM, illustrates that the defect is 
not fully expressed in all cells. Moreover, the fact that cata­
lase, acyl-CoA oxidase, 3-ketoacyl-CoAthiolase, and alanine/ 
glyoxylate aminotransferase are imported (acyl-CoA oxidase 
and 3-ketoacyl-CoA thiolase make use of PTSI and PTSII, 
respectively), indicates that the routing and translocation pro­
cesses for these proteins are functioning. The question 
remains by which mechanisms these cells have accomplished 
the restoration of the defect. This restoration appears to be 
incomplete as catalase was also visualized in the cytoplasm of 
these cells.
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